Skip to content
★ Sign in to follow
SH

Scott Haufe

H-Cyte, Inc.
Total declarations
9
Company
1
▲ Purchases (4 ops.)
€662k
▼ Sales (2 ops.)
€69k

Latest filing published 01 Nov 2017 for H-CYTE, INC., €13k.

Filing timeline

BuySale
Scott Haufe

Insider track record

Disclosed buys
4
Disclosed sells
2
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 25 Nov 2015 · 4002 days ago · €6,343
    -14.0%
    Entry US$1,640.00 · Close at T+365 US$1,410.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Scott Haufe: trading record in brief

All filings by Scott Haufe on record concern H-Cyte, Inc. Over a trading history stretching from 22 June 2015 to 30 October 2017, the count stands at 9 filings.

Both buying and selling appear: 4 purchases worth €662k, against 2 sales worth €69k. On balance, insiders were net buyers of €593k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. Since January 2017: 3 purchases and 2 sales on the market.

In size, the median ticket on the buying side is €179k.

The latest filing, published on 1 November 2017, reports a share grant of €13k in H-Cyte, Inc. The last purchase on record was published on 18 April 2017, which is 3,492 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Scott Haufe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◆
    DirectorExecutivesH-Cyte, Inc.
    15,001 USD15SEC
    12,821 shares@ US$1.1743.6% of flowCommon StockSEC:0001493152-17-012291:0
  • ▼
    DirectorExecutivesH-Cyte, Inc.
    59,500 USD0SEC
    50,000 shares@ US$1.19Common StockSEC:0001415889-17-001545:0
  • ▼
    DirectorExecutivesH-Cyte, Inc.
    23,600 USD0SEC
    20,000 shares@ US$1.18Common StockSEC:0001415889-17-001545:1
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    62,500 USD0SEC
    50,000 shares@ US$1.25Common StockSEC:0001415889-17-000649:0
    Canonical exit: 17 Jul 2017 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    323,289 USD0SEC
    250,612 shares@ US$1.29Common StockSEC:0001415889-17-000516:0
    Canonical exit: 26 Jun 2017 (T+90)
  • ◆
    DirectorExecutivesH-Cyte, Inc.
    30,000 USD17SEC
    21,739 shares@ US$1.3856.4% of flowCommon StockSEC:0001415889-17-000099:0
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    6,750 USD0SEC
    5,000 shares@ US$1.35Common StockSEC:0001415889-15-003887:0
    Canonical exit: 21 Feb 2016 (T+90)
  • ◆
    DirectorExecutivesH-Cyte, Inc.
    81,250 USD0SEC
    25,000 shares@ US$3.25Common StockSEC:0001415889-15-002176:0

8 of 8 declarations